
Liver-on-a-chip
Can a perfused, bioprinted liver tissue predict how the human liver handles a drug?
The project builds a perfusable, 3D-bioprinted human liver-on-a-chip from a silk fibroin–decellularized extracellular matrix (dECM) bioink. Extrusion bioprinting lays down the hepatic microarchitecture; microfluidic perfusion keeps the tissue fed so hepatocytes can work long-term.
- Bioink: silk fibroin combined with liver-derived dECM
- Build: extrusion bioprinting coupled with microfluidic perfusion
- Use: drug metabolism, hepatotoxicity screening, and ADME profiling
Host: Prof. F. Philipp Seib, Chair of Pharmaceutical Technology & Biopharmaceutics, Institute of Pharmacy. Funded by a Marie Skłodowska-Curie Postdoctoral Fellowship (Horizon Europe), starting 1 September 2026.




